374 related articles for article (PubMed ID: 24394630)
1. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
[TBL] [Abstract][Full Text] [Related]
2. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
[TBL] [Abstract][Full Text] [Related]
3. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
4. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Dizbay M; Tunccan OG; Sezer BE; Hizel K
Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
[TBL] [Abstract][Full Text] [Related]
9. The impact of possible clonal spread of Acinetobacter baumannii complex bacteremia.
Hsu HY; Chao CM
Crit Care Med; 2014 Sep; 42(9):e628. PubMed ID: 25126810
[No Abstract] [Full Text] [Related]
10. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
11. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
Young LS; Sabel AL; Price CS
Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
[TBL] [Abstract][Full Text] [Related]
13. Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia.
Chuang YC; Chang SC; Wang WK
Crit Care Med; 2012 Aug; 40(8):2273-80. PubMed ID: 22809902
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for imipenem-nonsusceptible Acinetobacter nosocomialis bloodstream infection.
Huang L; Chen TL; Lee YT; Lee MH; Kuo SC; Yu KW; Dou HY; Fung CP
J Microbiol Immunol Infect; 2014 Aug; 47(4):311-7. PubMed ID: 23642729
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
[TBL] [Abstract][Full Text] [Related]
18. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia.
Chuang YC; Sheng WH; Li SY; Lin YC; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2011 Feb; 52(3):352-60. PubMed ID: 21193494
[TBL] [Abstract][Full Text] [Related]
19. Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.
Fitzpatrick MA; Ozer E; Bolon MK; Hauser AR
J Infect; 2015 Feb; 70(2):144-52. PubMed ID: 25246361
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
